Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.1B | 6.9B | 7.4B | 7.5B |
Cost of revenue | 4.9B | 4.8B | 5.2B | 5.3B |
Gross profit | 2.1B | 2.0B | 2.1B | 2.2B |
Operating expense | ||||
Research & development | 70.2M | 173.7M | 89.0M | 78.9M |
Selling general and admin | 697.6M | 666.9M | 819.0M | 521.3M |
Other operating expenses | 64.2M | 111.8M | 55.9M | 69.5M |
Operating income | 1.5B | 1.0B | 1.4B | 1.4B |
Non operating interest income | ||||
Income | 10.9M | 41.1M | 13.6M | 14.0M |
Expense | 35.7M | 62.3M | 82.1M | 20.8M |
Other income expense | — | — | — | — |
Pretax income | 1.6B | 1.2B | 2.6B | 1.6B |
Tax provision | 341.0M | 281.0M | 564.6M | 351.5M |
Net income | 1.3B | 914.5M | 2.0B | 1.3B |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 19.6B | — | — | — |
Diluted average shares | 19.6B | — | — | — |
EBITDA | 1.7B | 1.3B | 2.6B | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -122.1M | -124.0M | -118.1M | -142.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |